NOVALIX

novalix-logo

NovAliX is focusing on the development of enabling chemistry and biophysical technologies to support the pharmaceutical industry's outsourcing needs from discovery to manufacturing. With proprietary SPR technology, X-ray protein crystallography, supramolecular mass spectrometry and chemistry, NovAliX offers comprehensive integrated services for small molecule drug discovery. With advanced NMR technologies, NovAliX provides fine characterization of biologics, thorough analysis of APIs and polymorphism studies to support pharmaceutical development and manufacturing teams.

#People #Financial #Website #More

NOVALIX

Social Links:

Industry:
Biotechnology

Founded:
2002-01-01

Address:
Illkirch, Alsace, France

Country:
France

Website Url:
http://www.novalix.com

Total Employee:
51+

Status:
Active

Contact:
+33 0 368 330 200

Email Addresses:
[email protected]

Total Funding:
2 M EUR

Technology used in webpage:
IPv6 Cloudflare Hosting Cloudflare DNS



Current Advisors List

jean-paul-renaud_image

Jean-Paul Renaud Initiator, Chairman & Scientific Organizer of the NovAliX Conferences "Biophysics in Drug Discovery" @ NovAliX
Board_member

Current Employees Featured

frank-hoonakker_image

Frank Hoonakker
Frank Hoonakker Head of eNovalys developpement @ NovAliX
Head of eNovalys developpement
2017-11-01

denis-zeyer_image

Denis Zeyer
Denis Zeyer CEO @ NovAliX
CEO

christophe-dubost_image

Christophe Dubost
Christophe Dubost Chief Financial Officer @ NovAliX
Chief Financial Officer

jean-paul-renaud_image

Jean-Paul Renaud
Jean-Paul Renaud Co-Founder @ NovAliX
Co-Founder
2002-11-01

not_available_image

Dino Moras
Dino Moras Co-Founder @ NovAliX
Co-Founder

not_available_image

Stephan Jenn
Stephan Jenn Co-Founder & President @ NovAliX
Co-Founder & President

Founder


not_available_image

Dino Moras

jean-paul-renaud_image

Jean-Paul Renaud

not_available_image

Stephan Jenn

Investors List

bpifrance_image

Bpifrance

Bpifrance investment in Venture Round - NovAliX

région-grand-est_image

Région Grand Est

Région Grand Est investment in Venture Round - NovAliX

Official Site Inspections

http://www.novalix.com

  • Host name: d624.dinaserver.com
  • IP address: 82.98.132.149
  • Location: Spain
  • Latitude: 40.4172
  • Longitude: -3.684
  • Timezone: Europe/Madrid

Loading ...

More informations about "NovAliX"

NovAliX - Preclinical CRO. Drug discovery services

Chemistry services to support drug discovery. NovAliX chemists have an unrivalled track record in custom synthesis, medicinal chemistry and process research. Our flexible organization and …See details»

NovAliX and Bruker forge global alliance

Strasbourg, France – August 7, 2024 – NovAliX, a Contract Research Organization (CRO) specializing in drug discovery, has formed a strategic partnership with Bruker, a leader in scientific instruments, under which Bruker …See details»

Drug Discovery Chemistry Services CRO and Medicinal …

NovAliX chemists have an unrivalled track record in custom synthesis, process research and medicinal chemistry. Also, our flexible organization and state-of-the-art technical capabilities allow us to deliver the most cost-effective and reliable …See details»

Galapagos and NovAliX enter into an integrated drug discovery ...

NovAliX is a fully integrated drug discovery CRO supporting therapeutic programs from target identification to the delivery of preclinical candidates.See details»

NovAliX - Crunchbase Company Profile & Funding

NovAliX is a company that aids managers, scientists, and project managers with drug discovery projects. View contacts for NovAliX to access new leads and connect with decision-makers.See details»

Bruker Announces Strategic Minority Investment in NovAliX

Aug 7, 2024 · Bruker Corporation (Nasdaq: BRKR) today announced a strategic investment in NovAliX , a preclinical Contract Research Organization (CRO) specializing in expert drug …See details»

Novalix - LinkedIn

Novalix is a premier drug discovery partner to biotech firms and pharmaceutical companies. We apply our exceptional scientific talent and exclusive resources across our platforms to improve the...See details»

Galapagos and NovAliX enter into an integrated drug discovery …

Mar 30, 2023 · NovAliX is a fully integrated drug discovery CRO supporting therapeutic programs from target identification to the delivery of preclinical candidates.See details»

NovAliX and Max Planck pen cancer, anti-infective pact …

Mar 6, 2024 · NovAliX has entered into a long-term partnership with the Max Planck Institute for Multidisciplinary Sciences to translate basic science research into new therapies, the preclinical CRO announced...See details»

NovAliX and Max Planck join forces to advance Cryo-EM driven …

Mar 6, 2024 · NovAliX, a specialized contract research organization dedicated to enabling drug discovery, today announces its long-term strategic partnership with the Max Planck Institute …See details»

NovAliX and Max Planck join forces

Mar 5, 2024 · Strasbourg, France, and Göttingen, Germany – March 5, 2024 – NovAliX, a specialized Contract Research Organization dedicated to enabling drug discovery, today announces its long-term strategic partnership with the …See details»

NovAliX - Scientist.com

Sep 16, 2021 · With a team of around 200 researchers, NovAliX has a unique biophysical platform operated by passionate expert scientists encompassing mass spectrometry, SPR, …See details»

NovAliX, Bruker team up to build new drug discovery methods

Aug 8, 2024 · Massachusetts-based manufacturer Bruker Corporation has announced a minority investment in the CRO. “This partnership with Bruker will fortify our leadership in biophysics …See details»

Galápagos and NovAliX: Pioneering Drug Discovery Collaboration …

Jul 18, 2023 · NovAliX operates as a drug discovery-focused Contract Research Organization (CRO) and boasts one of the most comprehensive biophysics platforms worldwide. The …See details»

Galapagos to transfer research site to NovAliX

Apr 10, 2023 · NovAliX, a French drug contract research organization (CRO), will acquire a research facility in Romainville, France, from the Belgian biotech firm Galapagos. Under the …See details»

Who we are - NovAliX

NovAliX has pioneered the concept and practice of insourcing in Europe, has engaged in risk-sharing collaborations with biotechnology investors, and has also formed an alliance with a …See details»

NovAliX - Products, Competitors, Financials, Employees, …

NovAliX is a France-based, client-centric organization providing outsourcing and insourcing research services for drug discovery. You're one click away from the most comprehensive, …See details»

NovAlix contributes to international drug discovery and …

Sep 6, 2021 · For almost two decades now, NovAlix has operated in the drug discovery and development sector. The Strasbourg-based company offers an expertise and its knowledge in …See details»

Collaborative Models - NovAliX Services

NovAliX is an agile and creative organization, which engages in diverse deal constructs and collaboration modalities to generate value for its partners. Advanced Collaborative Models …See details»

Discovery of UCB9386: A Potent, Selective, and Brain-Penetrant …

2 days ago · Nuak1 (NUAK family SnF1-like kinase-1) is a serine-threonine kinase and a member of the AMPK family. Interest in Nuak1 has increased over the years due to the role it plays in …See details»

linkstock.net © 2022. All rights reserved